Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)

SHA:688319 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 10, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	10,554	4,303	6,417	5,621	14,513	-
Market Cap Growth	145.98%	-32.95%	14.17%	-61.27%	-	-
Enterprise Value	10,742	4,422	6,267	5,420	14,115	-
Last Close Price	26.00	10.60	15.74	13.81	35.67	-
PE Ratio	163.80	207.29	365.54	211.50	134.42	-
Forward PE	247.62	98.61	60.77	38.44	59.68	-
PS Ratio	14.88	7.31	12.94	10.27	29.79	-
PB Ratio	10.90	4.61	6.90	6.30	17.18	-
P/TBV Ratio	11.20	4.74	7.13	6.51	17.47	-
P/OCF Ratio	124.11	-	145.85	-	363.16	-
EV/Sales Ratio	15.15	7.51	12.63	9.90	28.97	-
EV/EBITDA Ratio	97.18	89.21	204.71	135.49	120.71	-
EV/EBIT Ratio	137.27	204.54	1787.91	368.70	150.33	-
Debt / Equity Ratio	0.41	0.39	0.26	0.15	0.05	0.07
Debt / EBITDA Ratio	3.59	6.79	6.93	3.35	0.33	0.60
Asset Turnover	0.39	0.34	0.32	0.41	0.53	0.57
Inventory Turnover	0.56	0.38	0.49	0.56	0.47	0.45
Quick Ratio	1.40	1.37	1.80	1.63	2.34	1.28
Current Ratio	1.53	1.53	1.96	1.78	2.56	1.51
Return on Equity (ROE)	6.66%	1.69%	1.26%	3.06%	17.68%	10.07%
Return on Assets (ROA)	2.68%	0.79%	0.14%	0.68%	6.33%	3.10%
Return on Capital (ROIC)	3.67%	1.10%	0.20%	0.96%	9.12%	4.63%
Return on Capital Employed (ROCE)	6.00%	1.80%	0.30%	1.50%	10.80%	7.00%
Earnings Yield	0.61%	0.48%	0.27%	0.47%	0.74%	-
FCF Yield	-0.40%	-5.04%	-1.96%	-4.01%	-0.21%	-
Dividend Yield	-	-	0.24%	-	-	-
Payout Ratio	22.54%	142.97%	34.11%	16.00%	0.95%	-
Buyback Yield / Dilution	0.46%	0.01%	-0.07%	-5.22%	-5.61%	-0.89%
Total Shareholder Return	0.46%	0.01%	0.17%	-5.22%	-5.61%	-0.89%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.